Encompass Health (EHC) to Release Earnings on Thursday

Encompass Health (NYSE:EHC) is projected to release its earnings data after the market closes on Thursday, February 6th. Analysts expect Encompass Health to post earnings of $1.05 per share and revenue of $1.38 billion for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business’s revenue was up 11.9% on a year-over-year basis. During the same period last year, the company posted $0.86 EPS. On average, analysts expect Encompass Health to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Encompass Health Price Performance

EHC stock opened at $95.93 on Thursday. Encompass Health has a 1 year low of $70.83 and a 1 year high of $104.55. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The business has a 50 day simple moving average of $96.58 and a 200-day simple moving average of $94.58. The firm has a market capitalization of $9.66 billion, a PE ratio of 23.17, a price-to-earnings-growth ratio of 1.13 and a beta of 0.89.

Analyst Ratings Changes

A number of equities research analysts have commented on EHC shares. KeyCorp lifted their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada lifted their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Truist Financial restated a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Finally, Barclays lifted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.